Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Quest and BC Cancer Agency to develop photodynamic therapies for lung cancer

Jan. 31, 2008

Avastin receives broad label extension in Europe for metastatic colorectal cancer

Jan. 31, 2008

Study finds endoscopic ultrasound-guided delivery of BrachySil safe

Jan. 31, 2008

Serenex collaborates with NCI for small-molecule Hsp90 inhibitors in lung cancer

Jan. 30, 2008

FDA approves IND for clinical phase II trial with uPA inhibitor WX-671

Jan. 30, 2008

Arno Therapeutics completes license agreements for novel targeted cancer compounds

Jan. 30, 2008

Phase II dose of E-7974 in 21-day schedule determined in solid tumor patients

Jan. 30, 2008

Synta and GlaxoSmithKline obtain FDA orphan drug status for elesclomol

Jan. 29, 2008

Nexavar approved in Japan for advanced renal cell carcinoma

Jan. 29, 2008

Pfizer engages ApoCell to support phase I clinical trial of novel cancer drug

Jan. 29, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...